The FDA has granted approval to fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) for treating adult patients with unresectable or metastatic, hormone receptor–positive, HER2-low (immunohistochemistry ...
If the link is not working, try using the right mouse button/save link target as... You can only log in once at a time on a download server. If you want to download a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback